These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2649002)

  • 1. [Some problems of the criteria for response evaluation of cancer chemotherapy of the digestive organs].
    Nakao I
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):302-6. PubMed ID: 2649002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of cases of complete response (CR) in esophageal and gastric cancer].
    Suzuki T; Okazumi S; Ochiai T
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2059-65. PubMed ID: 11103237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of criteria for complete response (CR) of primary site to treatment of esophageal cancer.
    Tahara M; Ohtsu A; Hironaka S; Boku N; Ishikura S; Miyata Y; Ogino T; Yoshida S
    Jpn J Clin Oncol; 2005 Jun; 35(6):316-23. PubMed ID: 15961436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between response and survival].
    Ohtsu A; Boku N; Miyata Y; Ohkuwa M
    Gan To Kagaku Ryoho; 2000 May; 27(5):689-95. PubMed ID: 10832436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative concurrent chemotherapy and radiation therapy followed by surgery for esophageal cancer.
    Yano M; Inoue M; Shiozaki H
    Ann Thorac Cardiovasc Surg; 2002 Jun; 8(3):123-30. PubMed ID: 12472392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of chemotherapy for esophagus and gastric cancer.
    Taguchi T
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):625-30. PubMed ID: 3835707
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG-ps) in patients receiving palliative chemotherapy for gastroesophageal cancer.
    Crumley AB; Stuart RC; McKernan M; McDonald AC; McMillan DC
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e325-9. PubMed ID: 17645468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Update on gastroenterology].
    Ychou M; Senesse P; Quénet F
    Bull Cancer; 2000 Jun; 87(6):455-61. PubMed ID: 10903787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current status of chemotherapy of advanced esophageal and gastric cancer].
    Ogawa M
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2097-103. PubMed ID: 7184390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four cases of simultaneous triple primary cancers of the hypopharynx, esophagus, and stomach.
    Ikeda Y; Tsukuda M; Ishitoya J; Arai Y; Matsuda H; Katori H; Taguchi T; Yoshida T; Ono M; Sakuma Y; Yagisawa M; Saito N
    Otolaryngol Head Neck Surg; 2005 May; 132(5):788-93. PubMed ID: 15886636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the histoculture drug response assay as a sensitivity test for anticancer agents.
    Suda S; Akiyama S; Sekiguchi H; Kasai Y; Ito K; Nakao A
    Surg Today; 2002; 32(6):477-81. PubMed ID: 12107769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alternative model for the evaluation of antitumor activity.
    Lavin PT
    Cancer Clin Trials; 1981; 4(4):451-7. PubMed ID: 7318127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The value of adjuvant and neoadjuvant chemotherapy in treatment of stomach carcinoma].
    Ausch C; Rosen HR; Schiessel R
    Wien Klin Wochenschr; 1996; 108(16):496-504. PubMed ID: 8967093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fractal dimension analysis: a new method for evaluating the response of anticancer therapy.
    Omori H; Nio Y; Yano S; Itakura M; Koike M; Toga T; Matsuura S
    Anticancer Res; 2002; 22(4):2347-54. PubMed ID: 12174925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interest of chronotherapy in multidisciplinary management of oesophageal and gastric cancers].
    Focan C; Kreutz F; Longrée L; Graas MP; Moeneclaey N; Demolin G; Focan-Henrard D
    Pathol Biol (Paris); 2007; 55(3-4):181-5. PubMed ID: 17418504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliative chemotherapy for recurrent and metastatic esophageal cancer.
    Grünberger B; Raderer M; Schmidinger M; Hejna M
    Anticancer Res; 2007; 27(4C):2705-14. PubMed ID: 17695436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preoperative neoadjuvant chemotherapy in esophago-cardial adenocarcinoma?].
    Geissler M
    Dtsch Med Wochenschr; 2006 Jun; 131(23):1344. PubMed ID: 16761207
    [No Abstract]   [Full Text] [Related]  

  • 18. [Critics and proposals for the response criteria of the Japan Lung Cancer Society].
    Ohnoshi T
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):311-5. PubMed ID: 2649004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical modulation of 5-FU--effect of low dose CDDP].
    Hirata K; Yamamitsu S; Tsuji A; Shirasaka T; Mukaiya M; Oikawa I; Kimura H; Sasaki K; Denno R
    Gan To Kagaku Ryoho; 1999 Mar; 26(4):467-75. PubMed ID: 10097743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The growing pains of neoadjuvant trials for gastroesophageal carcinoma.
    Volpe C
    Ann Surg Oncol; 2006 Mar; 13(3):285-7. PubMed ID: 16450217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.